首页> 外文期刊>Pharmacological reviews >Vascular adrenoceptors: an update.
【24h】

Vascular adrenoceptors: an update.

机译:血管肾上腺素受体:更新。

获取原文
获取原文并翻译 | 示例
       

摘要

The total and regional peripheral resistance and capacitance of the vascular system is regulated by the sympathetic nervous system, which influences the vasculature mainly through changes in the release of catecholamines from both the sympathetic nerve terminals and the adrenal medulla. The knowledge of the targets for noradrenaline and adrenaline, the main endogenous catecholamines mediating that influence, has recently been greatly expanded. From two types of adrenoceptors (alpha and beta), we have now nine subtypes (alpha1A, alpha1B, alpha1D, alpha2A/D, alpha2B, alpha2A/D, beta1, beta2, and beta3) and two other candidates (alpha1L and beta4), which may be conformational states of alpha1A and beta1-adrenoceptors, respectively. The vascular endothelium is now known to be more than a pure anatomical entity, which smoothly contacts the blood and forms a passive barrier against plasma lipids. Instead, the endothelium is an important organ possessing at least five different adrenoceptor subtypes (alpha2A/D, alpha2C, beta1, beta2, and beta3), which either directly or through the release of nitric oxide actively participate in the regulation of the vascular tone. The availability of transgenic models has resulted in a stepwise progression toward the identification of the role of each adrenoceptor subtype in the regulation of blood pressure and fine-tuning of blood supply to the different organs: alpha2A/D-adrenoceptors are involved in the central control of blood pressure; alpha1-(primarily) and alpha2B-adrenoceptors (secondarily) contribute to the peripheral regulation of vascular tone; and alpha2A/D- and alpha2C-adrenoceptors modulate transmitter release. The increased knowledge on the involvement of vascular adrenoceptors in many diseases like Raynaud's, scleroderma, several neurological degenerative diseases (familial amyloidotic polyneuropathy, Parkinson disease, multiple-system atrophy), some kinds of hypertension, etc., will contribute to new and better therapeutic approaches.
机译:交感神经系统调节血管系统的总的和区域性外周阻力和电容,交感神经系统主要通过交感神经末梢和肾上腺髓质中儿茶酚胺的释放变化来影响脉管系统。最近,极大地扩展了去甲肾上腺素和肾上腺素(介导这种影响的主要内源性儿茶酚胺)的靶标知识。从两种类型的肾上腺素受体(α和β)中,我们现在有9个亚型(α1A,α1B,α1D,α2A/ D,α2B,α2A/ D,β1,β2和β3)和另外两种候选物(α1L和β4),可能分别是alpha1A和beta1-肾上腺素受体的构象状态。现在已知,血管内皮不仅仅是一种纯解剖学实体,它可以平滑地接触血液并形成针对血浆脂质的被动屏障。相反,内皮是重要的器官,具有至少五种不同的肾上腺素受体亚型(α2A/ D,α2C,β1,β2和β3),它们直接或通过释放一氧化氮积极参与血管张力的调节。转基因模型的可用性已导致逐步向识别每种肾上腺素受体亚型在血压调节中的作用和对不同器官的血液供应进行微调:α2A/ D肾上腺素受体参与了中央控制血压α1-(主要)和α2B-肾上腺素能受体(第二)有助于调节血管紧张度。 α2A/ D-和α2C-肾上腺素受体调节发射器的释放。对血管性肾上腺素能受体参与许多疾病(例如雷诺氏病,硬皮病,几种神经退行性疾病(家族性淀粉样变性多发性神经病,帕金森病,多系统萎缩症),某些高血压等)的了解增加,将有助于新的更好的治疗方法方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号